Upload
grewal-yankeejatt
View
239
Download
0
Embed Size (px)
Citation preview
8/7/2019 Introduction of nanotechnolog grewal
1/22
NANOPARTICL
ES
Submitted by: Lakhwinder Singh Submitted to:
Ms. Lotika Bajaj
B-Pharmacy7th semester
Assistant Professor
(8150152018) M. pharm
(pharmaceutics)
1
8/7/2019 Introduction of nanotechnolog grewal
2/22
P.C.T.E. Institute of Pharmacy (Jhandey)
Ludhiana.
ACKNOWLEDGEMENT
I owe heartiest thanks to many people who helped and supported me during the
writing of this project. My deepest thanks to Ms. Lotika Bajaj my Guide of the
project for guiding and paying attention and care. She has done a lot to go
through the project and make necessary corrections as and when needed. I
express my thanks to our dean, Dr. B.S. Sekhon, for extending his support. I
would also thank my Institution and my faculty members without whom this
project would have been a distant reality. I also extend my heartfelt thanks to
my family, friends and well wishers.
Lakhwinder Singh Ms. Lotika Bajaj
(8150152018) Assistant Professor
2
8/7/2019 Introduction of nanotechnolog grewal
3/22
B-pharma (7th semester) M-Pharma (pharmaceutics)
INDEX
Sr. No. CONTENT Pg. No.
1. NANOTECHNOLOGY 4
2.CURRENT STATUS
5
3.NANOPARTICLES
6
4. HISTORY OF NANOPARTICLES 6-7
5.ADVANTAGES OF NANOPARTICLES
7
6.LIMITATIONS OF NANOPARTICLES
8
7. TYPES OF NANOPARTICLES 8
8.
MATERIALS USED FOR PREPARATION OF
NANOPARTICLES 9-11
9.METHODS OF PREPARATION OF NANOPARTICLES
11-13
10.CHACTERIZATION OF NANOPARTICLES
13-14
11.ZETA POTENTIAL 15
12.BLOOD BRAIN BARRIER
16
13.NANOPARTICLES CROSSES BLOOD BRAIN BARRIER
17
14. APPLICATIONS OF NANOPARTICLES 17-18
3
8/7/2019 Introduction of nanotechnolog grewal
4/22
15.DRUG FORMULATIONS OF NANOPARTICLES
18
16. REFERENCES 19-21
NANOTECHNOLOGY
The U.S. National Nanotechnology Initiative defines NT as the understanding and control of
matter at dimensions of roughly 1 to 100 nanometres. Nanotechnology involves imaging,
measuring, modelling, and manipulating matter at this length scale.
The Europeans define it more simply as the technology dealing with applications and
products with engineered structures smaller than 100 nanometres. For comparison, a single
human hair is approximately 80,000 nanometres wide, and a red blood cell is approximately
7,000 nanometres wide [1].
Nanotechnology (NT) is the production and use of materials with purposely engineered
features close to the atomic or molecular scale. NT deals with putting things together atom
by- atom and with structures so small that they are invisible to the naked eye. It provides the
ability to create materials, devices and systems with fundamentally new functions and
properties. The promise of NT is enormous. It has implications for almost every type of
manufacturing process and product. Potential NT applications in the next few decades could
produce huge increases in computer speed and storage capacity, therapies for several
different types of cancer, much more efficient lighting and battery storage, a major reduction
in the cost of desalinating water, clothes that never stain and glass that never needs cleaning.
While the benefits are almost limitless, they will be realized only if the potential adverse
effects of NT are examined and managed. NT is new, but the effort to understand and manage
its effects will be long-term. As the world community tries to reduce the adverse effects of
the technology, our understanding of these effects will steadily increase. At the same time, as
4
8/7/2019 Introduction of nanotechnolog grewal
5/22
the technology advances and commercial applications multiply, new challenges and problems
will arise. NT covers a wide variety of processes and materials [2].
Nanotechnology is the study of manipulation or self assembly of individual atoms, molecules
or molecular clusters to create materials and devices with vastly different properties. It also
involves the design, production and application of structures, devices and systems by
controlling the shape and size at the nanometre scale. The first mention of some of the
distinguishing concepts in nanotechnology was given by physicist Richard Feynman on 1959.
He noted the changing magnitude of various physical phenomena: gravity would become less
important, surface tension, etc. This basic idea appears feasible and exponential assembly
enhances it with parallelism to produce a useful quantity of end products [3].
CURRENT STATUS
The present age is characterized by accelerating technological development, and NT is
developing extraordinarily rapidly. The field was not identified until 1959, when Nobel
physicist Richard Feynman called attention to the opportunities in the realm of the
staggeringly small. In 2001, Science magazine named NT the breakthrough of the year.
Currently, there are several hundred different commercial applications of NT. The National
Science Foundation predicts that nano-related goods and services could be a $1 trillion
market by 2015.
The rapid development of NT also means that government managers always will be operating
with outdated information, and that data about NT effects will lag behind commercial
applications. Priorities for research and for regulation will need to shift constantly. We have
moved into a world which is, as David Rejeski states, dominated by rapid improvements in
products, processes, and organizations, all moving at rates that exceed the ability of our
5
8/7/2019 Introduction of nanotechnolog grewal
6/22
traditional governing institutions to adapt or shape outcomes. He warns, If you think that
any existing regulatory framework can keep pace with this rate of change, think again [4].
NANOPARTICLES
Nanoparticles are defined as particulate dispersions or solid particles with a size in the range
of 10-1000nm. The drug is dissolved, entrapped, encapsulated or attached to a nanoparticle
matrix [5]. Depending upon the method of preparation, nanoparticles, nanospheres or
nanocapsules can be obtained. Nanocapsules are systems in which the drug is confined to a
cavity surrounded by a unique polymer membrane, while nanospheres are matrix systems in
which the drug is physically and uniformly dispersed [6]. In recent years, biodegradable
polymeric nanoparticles, particularly those coated with hydrophilic polymer such as
polyethylene glycol (PEG) known as long-circulating particles, have been used as potential
drug delivery devices because of their ability to circulate for a prolonged period time target a
particular organ, as carriers of DNA in gene therapy, and their ability to deliver proteins,
peptides and genes [7].
Other names of nanoparticles
Ultra fine particles, clusters, nanocrystals, quantum dots of colloids, aerosols, Hydrosols,
organosols [5].
HISTORY OF NANOPARTICLES
1960s~1970s, preparation of nanoparticles by gas evaporation-condensation method
Quantum confinement (Kubo) effect
6
8/7/2019 Introduction of nanotechnolog grewal
7/22
1981-1986 Japan, Ultra-Fine Particle Project under the auspices of the Exploratory
Research for Advanced Technology program (ERATO)
- Preparation, characterization, properties, applications
1981 G.K. Binnig H. Roher (IBM Zurich): invented scanning tunnelling microscope
(1985 Nobel prize)
- allows atomic-scale three-dimensional profiles of surfaces to be obtained
1985 R.Smalley, R.Curl and H.Kroto discovered C60 (Nobel Prize in 1996).
- Officially known as buckminsterfullerene (exactly like a football).
1987 B.J. van Wees and H. van Houten (Netherlands)/D. Wharam and M.Pepper
(Cambridge U.), observed quantization of conductance (step in I-V curve)
- Coulomb blockade, single electron transistor
1991, Iijima made carbon nanotubes (multi-walled), Single-walled(1993)
1999, Self assembly of molecules on metal nanoparticles
1996 NSF et al., assessed current worldwide status of nanoscience and
nanotechnology
2004,Silica nanoshells coated with gold(Rice University and the University of Texas )
- killed cancerous tumours, when exposed to an external source of near infrared light [8].
ADVANTAGES OF NANOPARTICLES
1. Particle size and surface characteristics of nanoparticles can be easily manipulated to
achieve both passive and active drug targeting after parenteral administration.
2. They control and sustain release of the drug during the transportation and at the site of
localization, altering organ distribution of the drug and subsequent clearance of the drug
so as to achieve increase in drug therapeutic efficacy and reduction in side effects.
7
8/7/2019 Introduction of nanotechnolog grewal
8/22
3. Controlled release and particle degradation characteristics can be readily modulated by the
choice of matrix constituents. Drug loading is relatively high and drugs can be
incorporated into the systems without any chemical reaction; this is an important factor
for preserving the drug activity.
4. Site-specific targeting can be achieved by attaching targeting ligands to surface of particles
or use of magnetic guidance.
5. The system can be used for various routes of administration including oral, nasal,
parenteral, intra-ocular etc. [9].
LIMITATIONS OF NANOPARTICLES
Their small size and large surface area can lead to particle-particle aggregation, making
physical handling of nanoparticles difficult in liquid and dry forms. In addition, small
particles size and large surface area readily result in limited drug loading and burst
release. These practical problems have to be overcome before nanoparticles can be used
clinically or made commercially available [9].
TYPES OF NANOPARTICLES
Types of Nanoparticles
In Medicine:
Liposome, Dendrimer, Iron oxide nanoparticles, Polymer-drug conjugate,
Polymeric nanoparticle.
a. Other Relevant or Related Items:
Ceramic engineering, Coating, Colloid, Colloid-facilitated transport, Colloidal
crystal, Colloidal gold, Eigencolloid, Gallium selenide, Indium selenide, Liposome,
Magnetic immunoassay, Magnetic nanoparticles, Micromeritics, Nano-
8
http://www.servinghistory.com/topics/Liposomehttp://www.servinghistory.com/topics/Liposomehttp://www.servinghistory.com/topics/Dendrimerhttp://www.servinghistory.com/topics/Iron_oxide_nanoparticleshttp://www.servinghistory.com/topics/Polymer-drug_conjugatehttp://www.servinghistory.com/topics/Polymeric_nanoparticlehttp://www.servinghistory.com/topics/Ceramic_engineeringhttp://www.servinghistory.com/topics/Coatinghttp://www.servinghistory.com/topics/Colloidhttp://www.servinghistory.com/topics/Colloid-facilitated_transporthttp://www.servinghistory.com/topics/Colloidal_crystalhttp://www.servinghistory.com/topics/Colloidal_crystalhttp://www.servinghistory.com/topics/Colloidal_goldhttp://www.servinghistory.com/topics/Eigencolloidhttp://www.servinghistory.com/topics/Gallium_selenidehttp://www.servinghistory.com/topics/Indium_selenidehttp://www.servinghistory.com/topics/Liposomehttp://www.servinghistory.com/topics/Magnetic_immunoassayhttp://www.servinghistory.com/topics/Magnetic_nanoparticleshttp://www.servinghistory.com/topics/Micromeriticshttp://www.servinghistory.com/topics/Nanobiotechnologyhttp://www.servinghistory.com/topics/Liposomehttp://www.servinghistory.com/topics/Dendrimerhttp://www.servinghistory.com/topics/Iron_oxide_nanoparticleshttp://www.servinghistory.com/topics/Polymer-drug_conjugatehttp://www.servinghistory.com/topics/Polymeric_nanoparticlehttp://www.servinghistory.com/topics/Ceramic_engineeringhttp://www.servinghistory.com/topics/Coatinghttp://www.servinghistory.com/topics/Colloidhttp://www.servinghistory.com/topics/Colloid-facilitated_transporthttp://www.servinghistory.com/topics/Colloidal_crystalhttp://www.servinghistory.com/topics/Colloidal_crystalhttp://www.servinghistory.com/topics/Colloidal_goldhttp://www.servinghistory.com/topics/Eigencolloidhttp://www.servinghistory.com/topics/Gallium_selenidehttp://www.servinghistory.com/topics/Indium_selenidehttp://www.servinghistory.com/topics/Liposomehttp://www.servinghistory.com/topics/Magnetic_immunoassayhttp://www.servinghistory.com/topics/Magnetic_nanoparticleshttp://www.servinghistory.com/topics/Micromeriticshttp://www.servinghistory.com/topics/Nanobiotechnology8/7/2019 Introduction of nanotechnolog grewal
9/22
biotechnology, Nanocrystalline silicon, Nanogeoscience, Nanomaterials,
Nanomedicine,Nanoparticle Tracking Analysis,Nanotechnology, Photonic crystal,
Plasmon, Quantum dot, Silicon, Silver Nano, Sol-gel, Transparent materials[10].
MATERIALS USED FOR PREPARATION
Nanoparticles can be prepared from a variety of materials such as proteins,
polysaccharides and synthetic polymers [11].
1) Protein Based Nanoparticles
Proteins are a class of natural molecules that have applications in both biological as well
as material fields [12].
a. Gelatin
Gelatin is one of the protein materials that can be used for the production of
nanoparticles. It is obtained by controlled hydrolysis of the fibrous, insoluble protein,
collagen, which is widely found as the major component of skin, bones and connective
tissue. Two different gelatins, A and B with different isoelectric points (IEP), are formed
following either acid or base hydrolysis, Characteristic features of gelatin are the high
content of the amino acids glycine, proline and alanine [12].
b. Albumin
Albumin is an attractive macromolecular carrier and widely used to prepare nanospheres
and nanocapsules, due to its availability in pure form and its biodegradability, nontoxicity
and nonimmmunogenicity. Both Bovine Serum Albumin or BSA and Human Serum
Albumin or HSA have been used. On the other hand, albumin nanoparticles are
biodegradable, easy to prepare in defined sizes, and carry reactive groups on their
surfaces that can be used for ligand binding and/or other surface modifications and also
9
http://www.servinghistory.com/topics/Nanobiotechnologyhttp://www.servinghistory.com/topics/Nanocrystalline_siliconhttp://www.servinghistory.com/topics/Nanogeosciencehttp://www.servinghistory.com/topics/Nanomaterialshttp://www.servinghistory.com/topics/Nanomedicinehttp://www.servinghistory.com/topics/Nanoparticle_Tracking_Analysishttp://www.servinghistory.com/topics/Nanotechnologyhttp://www.servinghistory.com/topics/Photonic_crystalhttp://www.servinghistory.com/topics/Plasmonhttp://www.servinghistory.com/topics/Quantum_dothttp://www.servinghistory.com/topics/Siliconhttp://www.servinghistory.com/topics/Silver_Nanohttp://www.servinghistory.com/topics/Sol-gelhttp://www.servinghistory.com/topics/Transparent_materialshttp://www.servinghistory.com/topics/Nanobiotechnologyhttp://www.servinghistory.com/topics/Nanocrystalline_siliconhttp://www.servinghistory.com/topics/Nanogeosciencehttp://www.servinghistory.com/topics/Nanomaterialshttp://www.servinghistory.com/topics/Nanomedicinehttp://www.servinghistory.com/topics/Nanoparticle_Tracking_Analysishttp://www.servinghistory.com/topics/Nanotechnologyhttp://www.servinghistory.com/topics/Photonic_crystalhttp://www.servinghistory.com/topics/Plasmonhttp://www.servinghistory.com/topics/Quantum_dothttp://www.servinghistory.com/topics/Siliconhttp://www.servinghistory.com/topics/Silver_Nanohttp://www.servinghistory.com/topics/Sol-gelhttp://www.servinghistory.com/topics/Transparent_materials8/7/2019 Introduction of nanotechnolog grewal
10/22
albumin nanoparticles offer the advantage that ligands can easily be attached by covalent
linkage [12].
c. Gliadin and legumin
For biological applications, vegetal particles have been derived from proteins such as
gliadin extracted fromgluten of wheat and vicillin or legumin extracted from pea seeds.
Gliadin appears to be a suitable polymer for the preparation of mucoadhesive
nanoparticles capable of adhering to the mucus layer. Gliadin nanoparticles (GNP) have
shown a great tropism for the upper gastrointestinal regions. This shows the high capacity
to interaction with the mucosa. In fact, this protein is rich in neutral and lipophilic
residues.
Legumin is also one of the main storage proteins in the pea seeds (Pisum sativum L.)
Legumin is an albuminous substance that resembles casein and functions as the source of
sulfur-containing amino acids in seed meals [12].
2) Polysaccharides Nanoparticles
Ganoderma lucidum (Lentinus edodes) has been reported to be a medicinal
mushroom for the treatment or prevention of many diseases, including AIDS, hepatitis B
and cancer. G. lucidum polysaccharide, a form of bioactive b-glucan, which is extracted
from G. lucidum, is one of efficacious ingredient groups of G. lucidum [13].
3) Synthetic polymer
Class examples
a. Biodegradable polymer
1. Polyester PLA,PGA,PHB
2. Polyanhydrides PCL,PMA,Polydioxanones
10
8/7/2019 Introduction of nanotechnolog grewal
11/22
3. Polyamide polysebacic acid, PTA
4. Phosphorous based polyphosphazenes, polyphosphonate,
b. Nonbiodegradable polymer
1. Cellulose derivatives CMC,EC,CA,CAP
2. Silicons PDS, colloidal silica
3. Acrylic polymers PMA,PMMA,PHEMA
4. Others PVP,EVA
The selection of matrix materials is dependent on many factors including:
(a) Size of nanoparticles required
(b) Inherent properties of the drug, e.g., aqueous solubility and stability
(c) Surface characteristics such as charge and permeability
(d) Degree of biodegradability, biocompatibility and toxicity
(e) Drug release profile desired
(f) Antigenicity of the final product [11].
METHODS OF PREPARATION
Nanoparticles have been prepared most frequency by three methods:
1. Dispersion of preformed polymers
2. Polymerization of monomers
3. Ionic gelation or coacervation of hydrophilic polymers
11
8/7/2019 Introduction of nanotechnolog grewal
12/22
1. Dispersion of preformed polymers
Dispersion of preformed polymers is a common technique used to prepare biodegradable
nanoparticles from poly lactic acid (PLA); poly D, L-glycolide, PLG; poly D, L-lactide-
co-glycolide (PLGA) and poly cyanoacrylate (PCA); this technique can be used in
various ways as described below [14,15,16].
a. Solvent evaporation method:
In this method, the polymer is dissolved in an organic solvent such as dichloromethane,
chloroform or ethyl acetate which is also used as the solvent for dissolving the
hydrophobic drug. The mixture of polymer and drug solution is then emulsified in an
aqueous solution containing a surfactant or emulsifying agent to form oil in water (o/w)
emulsion. After the formation of stable emulsion, the organic solvent is evaporated either
by reducing the pressure or by continuous stirring. Particle size was found to be
influenced by the type and concentrations of stabilizer, homogenizer speed and polymer
concentration [17]. In order to produce small particle size, often a high-speed
homogenization or ultrasonication may be employed [18].
b. Spontaneous emulsification or solvent diffusion method:
This is a modified version of solvent evaporation method. In this method, the water
miscible solvent along with a small amount of the water immiscible organic solvent is
used as an oil phase. Due to the spontaneous diffusion of solvents an interfacial
turbulence is created between the two phases leading to the formation of small particles.
As the concentration of water miscible solvent increases, a decrease in the size of particle
can be achieved. Both solvent evaporation and solvent diffusion methods can be used for
hydrophobic or hydrophilic drugs. In the case of hydrophilic drug, a multiple w/o/w
emulsion needs to be formed with the drug dissolved in the internal aqueous phase [19].
12
8/7/2019 Introduction of nanotechnolog grewal
13/22
1. Polymerization method
In this method, monomers are polymerized to form nanoparticles in an aqueous solution.
Drug is incorporated either by being dissolved in the polymerization medium or by
adsorption onto the nanoparticles after polymerization completed. The nanoparticle
suspension is then purified to remove various stabilizers and surfactants employed for
polymerization by ultracentrifugation and re-suspending the particles in an isotonic
surfactant-free medium. This technique has been reported for making
polybutylcyanoacrylate or poly (alkylcyanoacrylate) nanoparticles. Nanocapsule
formation and their particle size depends on the concentration of the surfactants and
stabilizers used [20].
2. Coacervation or ionic gelation method
Much research has been focused on the preparation of nanoparticles using biodegradable
hydrophilic polymers such as chitosan, gelatine and sodium alginate. Calvo and co-
workers developed a method for preparing hydrophilic chitosan nanoparticles by ionic
gelation. The method involves a mixture of two aqueous phases, of which one is the
polymer chitosan, a di-block co-polymer ethylene oxide or propylene oxide (PEO-PPO)
and the other is a polyanion sodium tripolyphosphate [21]. In this method, positively
charged amino group of chitosan interacts with negative charged tripolyphosphate to form
coacervates with a size in the range of nanometer. Coacervates are formed as a result of
electrostatic interaction between two aqueous phases, whereas, ionic gelation involves the
material undergoing transition from liquid to gel due to ionic interaction conditions at
room temperature [22].
METHODS OF CHARACTERIZATION OF NANOPARTICLES
13
8/7/2019 Introduction of nanotechnolog grewal
14/22
1) Particle size
a) A Photon correlation spectroscopy technique based on dynamic laser light scattering
due to Brownian motion of particles in solution/suspension, suitable for measurement of
particles in the range of 3 nm to 3 mm. The Photon correlation spectroscopy
(hydrodynamic diameters) diameters are based on the amount of light scattered from the
nanoparticles.
b) Transmission electron microscopy uses electron transmitted through the specimen to
determine the overall shape & morphology of the particle.
c) Scanning electron microscopy uses electron transmitted from the specimen to
determine the overall shape & morphology of the particle.
d) Scanned probe microscopes
e) Polarization intensity differertial scattering (PIDS) measures the particle size as 40.
f) Field flow fractionation based on the elution of the small particles when placed on a
parabolic flow profile.All the eluted fractions are analyzed by multi angle light scattering
(MALS) where a photo meter records the scattering signal of the particles & calculates X-
ray diffraction.
2) Molecular weight
a) Gel chromatograpy
b) Static secondary ion mass spectrometer
c) Atomic force microscopy
3) Surface element analysis
14
8/7/2019 Introduction of nanotechnolog grewal
15/22
a) X-ray photoelectron spectroscopy
b) Electrophoresis
c) Laser Doppler anaemomometry
d) Amplitude-weighted phase structure
e) X ray diffraction
4) Density
a) Helium compression pychnometry
b) Contact angle mearurement
c) Hydrophobic Interaction chromatography.
ZETA POTENTIAL
The zeta potential of a particle is the overall charge that the particle acquires in a
particular medium and can be measured on a Zetasizer Nano instrument. The magnitude
of the measured zeta potential is an indication of the repulsive force that is present and
can be used to predict the long-term stability of the product. If all the particles in
suspension have a large negative or positive zeta potential then they will tend to repel
each other and there is no tendency for the particles to come together. However, if the
particles have low zeta potential values then there is no force to prevent the particles
coming together and flocculating. The effect of the pH, concentration of an additive or the
ionic strength of the medium on the zeta potential and rheological properties can give
information in formulating the product to give maximum stability. The effect of these
parameters on the stability of particle dispersion can be automatically determined by
15
http://www.malvern.com/LabEng/industry/nanotechnology/zetasizer_nano_nanoparticles.htmhttp://www.malvern.com/LabEng/industry/nanotechnology/zetasizer_nano_nanoparticles.htm8/7/2019 Introduction of nanotechnolog grewal
16/22
using an autotitrator. The Malvern Multi Purpose Titrator(MPT-2) is a device capable of
performing such titrations in conjunction with the Zetasizer Nano series. In addition, any
one of the Malvern rheometer range can be used for providing complementary
information [25].
Drug loading
Ideally, a successful nanoparticulate system should have a high drug-loading capacity
thereby reduce the quantity of matrix materials for administration. Drug loading can be
done by two methods:
Incorporating at the time of nanoparticles production (incorporation method)
Adsorbing the drug after formation of nanoparticles by incubating the carrier with a
concentrated drug solution.
Drug loading depend on the solid-state drug solubility in matrix material or polymer
(solid dissolution or dispersion), which is related to the polymer composition, the
molecular weight, the drug polymer interaction [26].
Drug release
To develop a successful nanoparticulate system, both drug release and polymer
biodegradation are important consideration factors.
In general, drug release rate depends on:
1) Solubility of drug
2) Desorption of the surface bound/ adsorbed drug
3) Drug diffusion through the nanoparticle matrix
4)Nanoparticle matrix erosion/degradation
5) Combination of erosion/diffusion process
16
http://www.malvern.com/LabEng/products/zetasizer/accessories/mpt2.htmhttp://www.malvern.com/LabEng/products/zetasizer/accessories/mpt2.htm8/7/2019 Introduction of nanotechnolog grewal
17/22
Thus solubility, diffusion and biodegradation of the matrix materials govern the release
process [27].
BLOOD BRAIN BARRIER
The blood-brain barrier (BBB) is a separation of circulatingbloodandcerebrospinal
fluid (CSF) in the central nervous system (CNS). It occurs along all capillaries and
consists of tight junctions around the capillaries that do not exist in normal
circulation. Endothelial cells restrict the diffusion of microscopic objects (e.g.bacteria)
and large orhydrophilic molecules into the CSF, while allowing the diffusion of
small hydrophobic molecules (O2, hormones, CO2). Cells of the barrier actively
transport metabolic products such as glucose across the barrier with specific proteins [28].
NANOPARTICLES CROSSES THE BLOOD BRAIN BARRIER
Nanotechnology may also help in the transfer of drugs across the BBB. Recently,
researchers have been trying to buildliposomes loaded with nanoparticles to gain access
through the BBB. More research is needed to determine which strategies will be most
effective and how they can be improved for patients withbrain tumors. The potential for
using BBB opening to target specific agents to brain tumors has just begun to be
explored. For example, radiolabeled polyethylene glycol coated hexadecylcyanoacrylate
nanospheres targeted and accumulated in a rat gliosarcoma. Delivering drugs across the
blood-brain barrier is one of the most promising applications of nanotechnology in
clinical neuroscience. Nanoparticles could potentially carry out multiple tasks in a
predefined sequence, which is very important in the delivery of drugs across the blood-
brain barrier.It should be noted that vascular endothelial cells and associatedpericytes are
often abnormal in tumors and that the blood-brain barrier may not always be intact in
17
http://en.wikipedia.org/wiki/Bloodhttp://en.wikipedia.org/wiki/Bloodhttp://en.wikipedia.org/wiki/Cerebrospinal_fluidhttp://en.wikipedia.org/wiki/Cerebrospinal_fluidhttp://en.wikipedia.org/wiki/Cerebrospinal_fluidhttp://en.wikipedia.org/wiki/Central_nervous_systemhttp://en.wikipedia.org/wiki/Endothelial_cellhttp://en.wikipedia.org/wiki/Bacteriahttp://en.wikipedia.org/wiki/Hydrophilehttp://en.wikipedia.org/wiki/Hydrophobehttp://en.wikipedia.org/wiki/Metabolismhttp://en.wikipedia.org/wiki/Liposomeshttp://en.wikipedia.org/wiki/Liposomeshttp://en.wikipedia.org/wiki/Brain_tumorhttp://en.wikipedia.org/wiki/Pericyteshttp://en.wikipedia.org/wiki/Pericyteshttp://en.wikipedia.org/wiki/Bloodhttp://en.wikipedia.org/wiki/Cerebrospinal_fluidhttp://en.wikipedia.org/wiki/Cerebrospinal_fluidhttp://en.wikipedia.org/wiki/Central_nervous_systemhttp://en.wikipedia.org/wiki/Endothelial_cellhttp://en.wikipedia.org/wiki/Bacteriahttp://en.wikipedia.org/wiki/Hydrophilehttp://en.wikipedia.org/wiki/Hydrophobehttp://en.wikipedia.org/wiki/Metabolismhttp://en.wikipedia.org/wiki/Liposomeshttp://en.wikipedia.org/wiki/Brain_tumorhttp://en.wikipedia.org/wiki/Pericytes8/7/2019 Introduction of nanotechnolog grewal
18/22
brain tumors. Also, thebasement membraneis sometimes incomplete. Other factors, such
as astrocytes, may contribute to the resistance of brain tumors to therapy [29,30,31].
APPLICATIONS OF NANOPARTICLES
While nanoparticles are important in a diverse set of fields, they can generally be
classified as one of two types: engineered or nonengineered.
Engineered nanoparticles are intentionally designed and created with physical properties
tailored to meet the needs of specific applications.
They can be end products in and of themselves, as in the case of quantum dots or
pharmaceutical drugs, or they can be components later incorporated into separate end
products, such as carbon black in rubber products, Either way, the particles physical
properties are extremely important to their performance and the performance of any
product into which they are ultimately incorporated. Nonengineered nanoparticles, on the
other hand, unintentionally generated or naturally produced, such as atmospheric
nanoparticles created during combustion. With non-engineered nanoparticles, physical
properties also play an important role as they determine whether or not ill effects will
occur as a result of the presence of these particles [32].
DRUGS FORMULATIONS
[33]
Technique Delivery Vehicle Drug Nanoparticle Size
Spray Drying Nanoparticle-
Containing
Microparticles
Prenlukast
Hemihydrate
100-430 nm
18
http://en.wikipedia.org/wiki/Basement_membranehttp://en.wikipedia.org/wiki/Basement_membranehttp://en.wikipedia.org/wiki/Astrocyteshttp://en.wikipedia.org/wiki/Basement_membranehttp://en.wikipedia.org/wiki/Astrocytes8/7/2019 Introduction of nanotechnolog grewal
19/22
Emulsion/Spray
Drying
Nanoparticle-
Containing
Microparticles
6-Coumarin 259 nm
Nanoparticle
Flocculation
Nanoparticle
Clusters
N/A 300-500 nm
Ionotropic
Ge;ation/Spray
Drying
Nanoparticle-
Containing
Microparticles
Insulin 300-500 nm
Supercritical
Fluid Extraction
Nebulized
Droplets
Indomethacin
or Ketoprofen
10-30 nm
REFERENCES
1. Davis J. Clarence; (2006) Managing the effect of Nanotechnology; 1-34.
2. Varmus H, Klausner R, et al. (2003) Grand challenges in global health. 302: 398399.
3. Sangamithra A.; PG Dept of food science & technology.
4. Mohanraj VJ and Chen y.; (2006); 5; Tropical Journal of Pharmaceutical Research,
(1): 561-573.
5. Langer R. (2000); Biomaterials in drug delivery and tissue engineering: one
laboratory's experience; (33): 94-101.
6. Bhadra D, Bhadra S, Jain P, Jain NK. (2002); Pegnology: a review of PEG-ylated
systems; (57): 5-29.
7. Kommareddy S, Tiwari SB, Amiji MM. (2005); Long-circulating polymeric
nanovectors for tumor-selective gene delivery ;( 4): 615-625.
8. Jian-Ming L, et al.; (2009); Current advances in research and clinical applications of
PLGA-based nanotechnology; 2009 May; 9(4):325-341.
19
8/7/2019 Introduction of nanotechnolog grewal
20/22
9. VJ Mohanraj1 and Y Chen; (2006); Tropical Journal of Pharmaceutical Research; 561-
573.
10.Salata OV, (2004); Application of nanoparticles in biology and medicine. J of
Nanobiotechnology;2:3.11.Kreuter J. (1994); Nanoparticles. In Colloidal drug delivery systems, J, K., Ed.
Marcel Dekker: New York; 219-342.
12.Jahanshahi M, Aghajani H, (2005); assembly and purification of nanostructure
bioproducts: protein nanoparticle characterizations Int.J. Nanosci.Nanotech; (1):9-
19.
13.GU-Ping Tangb and Jian-Qing Gao;(2010); journal of pharmacy and pharmacology;
139-140.
14.Kompella UB, Bandi N, Ayalasomayajula SP.(2001) Poly(lactic acid) nanoparticles
for sustained release of budesonide. Drug Deliv. Technol; (1): 1-7.
15.Ravi MN, Bakowsky U, Lehr CM(2004); Preparation and characterization of cationic
PLGA nanospheres as DNA carriers. Biomaterials; (25): 1771-1777.
16.Ding J, Zhou JJ, GAO, XJ, et al; (2001); PEGylated polycyanoacrylate
nanoparticles as tumor necrosis factor-[alpha] carriers ;( 71): 287-296.
17.Kwon, HY, Lee JY, Choi SW, Jang Y, Kim JH. ;( 2001) ; Preparation of PLGA
nanoparticles containing estrogen by emulsification-diffusion method ;( 182);
123-130.
18.Zambaux M, et al; (1998); Influence of experimental parameters on the characteristics
of poly (lactic acid) Nanoparticles prepared by double emulsion method; (50);
31-40.
19.Niwa T, et al;(1993); Preparation of biodegradable nanoparticles of water-soluble and
insoluble drugs;(25): 89-98.
20
8/7/2019 Introduction of nanotechnolog grewal
21/22
20.Zhang Q, Shen Z, Nagai T. (2001); prolonged hypoglycaemic effect of insulin on
nanoparticles; 218: 75-80.
21.Calvo P, et al;(1997); Novel hydrophilic chitosan-polyethylene oxide nanoprticles as
protein carriers; (63): 125-132.
22.Calvo P, et al; (1997); Chitosan and chitosan/ethylene oxide-propylene oxide block
copolymer nanoparticles as novel carriers forproteins and vaccines; (14): 1431-
1436.
23.Yogesh Patil, Udaya Toti, Ayman Khdair, Linan Ma, and Jayanth Panyam; (2009);
Single-Step Surface Functionalization of Polymeric Nanoparticles for Targeted Drug
Delivery; 859-866.
24. Panyam J, Labhasetwar V. (2003); Biodegradable nanoparticles for drug and gene
delivery to cells and tissue; (55): 329-47.
25. Sanyogitta Puri; (2007); noval functionalized polymers for nanoparticle formulations
with anticancer drugs; 63-65.
26. Govender T, et al; (1999); PLGA nanoparticles prepared by nanoprecipitation: drug
loading and release studies of a water soluble drug; (57): 171-185.
27.Magenheim B, Levy MY, Benita S. (1993); a new in vitro technique for the evaluation
of drug release profile; (94); 115-123.
28.Hamilton RD, Foss AJ, Leach L (2007)."Establishment of a human in vitro model of
the outer blood-retinal barrier".Journal of Anatomy 211 (6); 1469-7580.
29.Brigger I, Morizet J, Aubert G, et al. (2002); "Poly (ethylene glycol)-coated
hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor
targeting". 303 (3); 92836.
30.Hashizume, H, et al; (2000); "Openings between defective endothelial cells explain
tumor vessel leakiness". American Journal of Pathology 156 (4); 13631380.
21
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2375847http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2375847http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2375847http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1876882http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1876882http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2375847http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2375847http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1876882http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=18768828/7/2019 Introduction of nanotechnolog grewal
22/22
31.Schneider, SW, et al; (2004). "Glioblastoma cells release factors that disrupt blood-
brain barrier features". Acta Neuropathologica 107 (3); 272276.
32. Jennifer Scalf, Paul West; (1998); Introduction to Nanoparticle Characterization with
AFM; 1-9.
33.Rogueda PG, Traini D. (2007); the nanoscale in pulmonary delivery. Part 2:
Formulation platforms; 4(6); 607620.
22